Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingde Xia

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Expert Opinion on Therapeutic Patents|May 16, 2009
Recent developments in CCR2 antagonistsMingde Xia, Zhihua Sui
Bioorganic & Medicinal Chemistry Letters|November 8, 2008
Synthesis and structure-activity relationship of 7-azaindole piperidine derivatives as CCR2 antagonistsMingde Xia, Cuifen Hou, Duane DeMong, et al.
Bioorganic & Medicinal Chemistry Letters|September 28, 2016
Tetrahydropyrazolo[4,3-c]pyridine derivatives as potent and peripherally selective cannabinoid-1 (CB1) receptor inverse agonistsBin Zhu, Jay M Matthews, Mingde Xia, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2008
Substituted dipiperidine alcohols as potent CCR2 antagonistsMingde Xia, Cuifen Hou, Duane Demong, et al.
Bioorganic & Medicinal Chemistry Letters|September 18, 2007
Synthesis and biological evaluation of phenyl piperidine derivatives as CCR2 antagonistsMingde Xia, Cuifen Hou, Scott Pollack, et al.
Bioorganic & Medicinal Chemistry Letters|September 28, 2016
Tetrahydroindazole derivatives as potent and peripherally selective cannabinoid-1 (CB1) receptor inverse agonistsJay M Matthews, James J McNally, Peter J Connolly, et al.
Journal of Medicinal Chemistry|October 13, 2007
Synthesis, structure-activity relationship and in vivo antiinflammatory efficacy of substituted dipiperidines as CCR2 antagonistsMingde Xia, Cuifen Hou, Duane E DeMong, et al.
Ebiomedicine|December 3, 2015
A Five-miRNA Panel Identified From a Multicentric Case-control Study Serves as a Novel Diagnostic Tool for Ethnically Diverse Non-small-cell Lung Cancer PatientsCheng Wang, Meng Ding, Mingde Xia, et al.
Bioorganic & Medicinal Chemistry Letters|February 16, 2013
Arylglycine derivatives as potent transient receptor potential melastatin 8 (TRPM8) antagonistsBin Zhu, Mingde Xia, Xiaoqing Xu, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Expert Opinion on Therapeutic Patents|May 16, 2009
Recent developments in CCR2 antagonistsMingde Xia, Zhihua Sui
Bioorganic & Medicinal Chemistry Letters|November 8, 2008
Synthesis and structure-activity relationship of 7-azaindole piperidine derivatives as CCR2 antagonistsMingde Xia, Cuifen Hou, Duane DeMong, et al.
Bioorganic & Medicinal Chemistry Letters|September 28, 2016
Tetrahydropyrazolo[4,3-c]pyridine derivatives as potent and peripherally selective cannabinoid-1 (CB1) receptor inverse agonistsBin Zhu, Jay M Matthews, Mingde Xia, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2008
Substituted dipiperidine alcohols as potent CCR2 antagonistsMingde Xia, Cuifen Hou, Duane Demong, et al.
Bioorganic & Medicinal Chemistry Letters|September 18, 2007
Synthesis and biological evaluation of phenyl piperidine derivatives as CCR2 antagonistsMingde Xia, Cuifen Hou, Scott Pollack, et al.
Bioorganic & Medicinal Chemistry Letters|September 28, 2016
Tetrahydroindazole derivatives as potent and peripherally selective cannabinoid-1 (CB1) receptor inverse agonistsJay M Matthews, James J McNally, Peter J Connolly, et al.
Journal of Medicinal Chemistry|October 13, 2007
Synthesis, structure-activity relationship and in vivo antiinflammatory efficacy of substituted dipiperidines as CCR2 antagonistsMingde Xia, Cuifen Hou, Duane E DeMong, et al.
Ebiomedicine|December 3, 2015
A Five-miRNA Panel Identified From a Multicentric Case-control Study Serves as a Novel Diagnostic Tool for Ethnically Diverse Non-small-cell Lung Cancer PatientsCheng Wang, Meng Ding, Mingde Xia, et al.
Bioorganic & Medicinal Chemistry Letters|February 16, 2013
Arylglycine derivatives as potent transient receptor potential melastatin 8 (TRPM8) antagonistsBin Zhu, Mingde Xia, Xiaoqing Xu, et al.
Pageof 1